Medtronic's (MDT) HUGO is Approved in Europe, Wells Fargo Talks Differentiation and Rev Levels

October 12, 2021 8:43 AM EDT Send to a Friend
Wells Fargo analyst Larry Biegelsen reiterated an Overweight rating and $151.00 price target on Medtronic, Inc. (NYSE: MDT) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login